Overview
Oral Aripiprazole Open-Label Rollover Study
Status:
Completed
Completed
Trial end date:
2012-07-01
2012-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to test the long-term safety and tolerability of oral aripiprazole in adolescent patients with schizophrenia.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.Treatments:
Aripiprazole
Criteria
Inclusion Criteria:- Subjects with a confirmed Axis I Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) diagnosis of schizophrenia who must have completed
Otsuka study 31-03-241 (NCT00102518) treatment of adolescent subjects with
schizophrenia
Exclusion Criteria:
- Patients with a co-morbid serious, uncontrolled systemic illness
- Patients with a significant risk of committing suicide